Subclinical hypothyroidism and cognitive impairment: Systematic review and meta-analysis

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 11, 2015, Pages 4240-4248

  Pasqualetti, Giuseppe ^a   Pagano, Gennaro ^b,c   Rengo, Giuseppe ^c,d   Ferrara, Nicola ^c,d   Monzani, Fabio ^a  

^a UNIVERSITY OF PISA   (Italy)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; COGNITION DISORDERS; COMPLICATION; FEMALE; HUMAN; HYPOTHYROIDISM; MALE; META ANALYSIS; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY; THYROID FUNCTION TEST; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COGNITION DISORDERS; FEMALE; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; THYROID FUNCTION TESTS; TREATMENT OUTCOME;

EID: 84958646150     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-2046     Document Type: Review

References (55)

1. Cooper DS, Biondi B. Subclinical thyroid disease. Lancet. 2012; 379:1142-1154.
2. Pearce SH, Brabant G, Duntas LH, et al. 2013 ETA guideline: management of subclinical hypothyroidism. Eur Thyroid J. 2013;2:215-228.
3. Ross DS. Subclinical hypothyroidism. In: Bravermann LE, Utiger RD. The Thyroid, A Fundamental and Clinical Text. 9th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2004:1072-1078.
4. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291:228-238.
5. Cooper DS. Clinical practice. Subclinical hypothyroidism. N Engl J Med. 2001;345:260-265.
6. Hennessey JV, Espaillat R. Subclinical hypothyroidism: a historical view and shifting prevalence. Int J Clin Pract. 2015;69:771-782.
7. Asvold BO, Vatten LJ, Bjøro T. Changes in the prevalence of hypothyroidism: theHUNTStudy in Norway. Eur J Endocrinol. 2013; 169:613-620.
8. Boucai L, Hollowell JG, Surks MI. An approach for development of age-, gender, and ethnicity-specific thyrotropin reference limits. Thyroid. 2011;21:5-11.
9. Tognini S, Pasqualetti G, Calsolaro V, Polini A, Monzani F. Cognitive function and quality of life in mild thyroid hormone deficiency. Recent Pat Endocr Metab Immune Drug Discov. 2014;8: 124-134.
10. Guideline for the evaluation of dementia and age-related cognitive decline: American Psychological Association Presidential Task Force on the Assessment of Age-Consistent Memory Decline, Dementia Washington DC US. Am Psychol. 1998;53:1298-1303.
11. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frölich M, Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. JAMA. 2004;292:2591-2599.
12. Tan ZS, Beiser A, Vasan RS, et al. Thyroid function and the risk of Alzheimer disease: the Framingham Study. Arch InternMed. 2008; 168:1514-1520.
13. Ceresini G, Lauretani F, Maggio M, et al. Thyroid function abnormalities and cognitive impairment in elderly people: results of the Invecchiare in Chianti study. J Am Geriatr Soc. 2009;57: 89-93.
14. Roberts LM, Pattison H, Roalfe A, et al. Is subclinical thyroid dysfunction in the elderly associated with depression or cognitive dysfunction? Ann Intern Med. 2006;145:573-581.
15. Jorde R, Waterloo K, Storhaug H, Nyrnes A, Sundsfjord J, Jenssen TG. Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment. J Clin Endocrinol Metab. 2006;91:145-153.
16. Hogervorst E, Huppert F, Matthews FE, Brayne C. Thyroid function and cognitive decline in the MRC Cognitive Function and Ageing Study. Psychoneuroendocrinology. 2008;33:1013-1022.
17. Park YJ, Lee EJ, Lee YJ, et al. Subclinical hypothyroidism (SCH) is not associated with metabolic derangement, cognitive impairment, depression or poor quality of life (QoL) in elderly subjects. Arch Gerontol Geriatr. 2010;50:e68-e73.
18. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Ann Intern Med. 2009;151:264-269.
19. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: proposal for reporting. Metaanalysis of observational studies in epidemiology(MOOSE)group. JAMA. 2000;283:2008-2012.
20. Rengo G, Pagano G, Squizzato A, et al. Oral anticoagulation therapy in heart failure patients in sinus rhythm: a systematic review and meta-analysis. PLoS One. 2013;8:e52952.
21. Pagano G, Rengo G, Pasqualetti G, et al. Cholinesterase inhibitors for Parkinson's disease: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2015;86:767-773.
22. Wells G, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp. Accessed August 25, 2015.
23. Sterne JA, Egger M, Smith GD. Systematic reviews in health are: investigating and dealing with publication and other biases in metaanalysis. BMJ. 2001;323:101-110.
24. Egger M, Smith GD, Phillips AM. Meta-analysis: principles and procedures. BMJ. 1997;315:1533-1537.
25. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. version 5.1.0 (updated March 2011) Available from www.cochrane-handbook.org. The Cochrane Collaboration 2011.
26. Whitehead A. Meta-analysis of Controlled Clinical Trials, 4. West Sussex, UK: John Wiley, Sons; 2002.
27. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
28. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560.
29. Tobias A. Assessing the influence of a single study in meta-analysis. Stata Tech Bull. 1999;47:15-17.
30. Sharp SJ. Meta-analysis regression. Stata Tech Bull. 1998;42: 16-22.
31. Thompson SG, Sharp SJ. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med. 1999;18:2693-2708.
32. Parsaik AK, Singh B, Roberts RO, et al. Hypothyroidism and risk of mild cognitive impairment in elderly persons: a populationbased study. JAMA Neurol. 2014;71:201-207.
33. Baldini IM, Vita A, Mauri MC, et al. Psychopathological and cognitive features in subclinical hypothyroidism. Prog Neuropsychopharmacol Biol Psychiatry. 1997;21:925-935.
34. Wijsman LW, de Craen AJ, Trompet S, et al. Subclinical thyroid dysfunction and cognitive decline in old age. PLoS One. 2013;8: e59199.
35. Yamamoto N, Ishizawa K, Ishikawa M, et al. Cognitive function with subclinical hypothyroidism in elderly people without dementia: one year follow up. Geriatr Gerontol Int. 2012;12:164-165.
36. E Silva SO, Chan IT, Lobo Santos MA, et al. Impact of thyroid status and age on comprehensive geriatric assessment. Endocrine. 2014;47:255-265.
37. Forti P, Olivelli V, Rietti E, et al. Serum thyroid-stimulating hormone as a predictor of cognitive impairment in an elderly cohort. Gerontology. 2012;58:41-49.
38. Kalmijn S, Mehta KM, Pols HA, Hofman A, Drexhage HA, Breteler MM. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clin Endocrinol (Oxf). 2000;53:733-737.
39. Resta F, Triggiani V, Barile G, et al. Subclinical hypothyroidism and cognitive dysfunction in the elderly. Endocr Metab Immune Disord Drug Targets. 2012;12:260-267.
40. Formiga F, Ferrer A, Padros G, Contra A, Corbella X, Pujol R; Octabaix Study Group. Thyroid status and functional and cognitive status at baseline and survival after 3 years of follow-up: the OCTABAIX study. Eur J Endocrinol. 2013;170:69-75.
41. Joffe RT1, Pearce EN, Hennessey JV, Ryan JJ, Stern RA. Subclinical hypothyroidism, mood, and cognition in older adults: a review. Int J Geriatr Psychiatry. 2013;28:111-118.
42. Mitchell AJ. A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment. J Psychiatr Res. 2009;43:411-431.
43. Franco-Marina F, García-González JJ, Wagner-Echeagaray F, et al. The Mini-Mental State Examination revisited: ceiling and floor effects after score adjustment for educational level in an aging Mexican population. Int Psychogeriatr. 2010;22:72-81.
44. Jensovsky J, Ruzicka E, Spackova N, Hejdukova B. Changes of event related potential and cognitive processes in patients with subclinical hypothyroidism after thyroxine treatment. Endocr Regul. 2002;36:115-122.
45. Monzani F, Del Guerra P, Caraccio N, et al. Subclinical hypothyroidism: neurobehavioral features and beneficial effect of L-thyroxine treatment. Clin Investig. 1993;71:367-371.
46. Rovet J, Daneman D. Congenital hypothyroidism: a review of current diagnostic and treatment practices in relation to neuropsychologic outcome. Paediatr Drugs. 2003;5:141-149.
47. Selva KA, Harper A, Downs A, Blasco PA, Lafranchi SH. Neurodevelopmental outcomes in congenital hypothyroidism: comparison of initial T4 dose and time to reach target T4 and TSH. J Pediatr. 2005;147:775-780.
48. Klein AH, Meltzer S, Kenny FM. Improved prognosis in congenital hypothyroidism treated before age three months. J Pediatr. 1972; 81:912-915.
49. de Jongh RT, Lips P, van SchoorNM,et al. Endogenous subclinical thyroid disorders, physical and cognitive function, depression, and mortality in older individuals. Eur J Endocrinol. 2011;165:545-554.
50. Lindeman RD, Schade DS, LaRue A, et al. Subclinical hypothyroidism in a biethnic, urban community. J Am Geriatr Soc. 1999; 47:703-709.
51. Hennessey JV, Espaillat R. Reversible morbidity markers in subclinical hypothyroidism. Postgrad Med. 2015;127:78-91.
52. Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56:1143-1153.
53. Pasqualetti G, Tognini S, Polini A, Caraccio N, Monzani F. Is subclinical hypothyroidism a cardiovascular risk factor in the elderly? J Clin Endocrinol Metab. 2013;98:2256-2266.
54. Rodondi N, den Elzen WP, Bauer DC, et al; Thyroid Studies Collaboration. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304:1365-1374.
55. Chaker L, Baumgartner C, den Elzen WP, et al; Thyroid Studies Collaboration. Subclinical hypothyroidism and the risk of stroke events and fatal stroke: an individual participant data analysis. J Clin Endocrinol Metab. 2015;100:2181-2191.